Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > US Clinical Study sites

<< Previous

Bullboard Posts

Next >>

Post by Eoganachton Oct 20, 2021 5:24pm

640 Views

Post# 34029483

US Clinical Study sites

Of the 7 US clinical study sites 5 have no mention of our trial on their clinical study search pages:

Virginia Urology
Urology Associates P.C.
MidLantic Urology
University of Wisconsin-Madison
Urology San Antonio

However the Carolina Urologic Research Center, Myrtle Beach, South Carolina, does list our trial:
https://carolinaurologicresearchcenter.com/current-trials/current-trials-bladder-cancer/

And the University of Chicago Medicine has a description of our trial which is even more detailed than the one on the UHN site.

https://www.uchicagomedicine.org/find-a-clinical-trial/clinical-trial/5/irb201049#headingEligibility

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec